Given that estrogen was previously found to synergize with p53 inactivation on breast carcinogenesis [17, 19], we set out to develop a mouse breast tumor model based on epithelium-specific inactivation of ERβ and p53. This evidence concerns the gene ESR2 and breast neoplasm.